Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$467,038,889
+$101,076,204 QoQ
Shares Held
389,384
-2.1% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#159
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chevy Chase Trust Holdings, LLC holds $1,644,743,184 across 12 Drug Manufacturers - General names. LLY ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
389,384 | $467,038,889 | |
| 2 | JNJ |
Johnson & Johnson
|
1,268,799 | $322,236,881 | |
| 3 | ABBV |
AbbVie Inc.
|
883,270 | $222,266,062 | |
| 4 | NVS |
Novartis AG
|
1,033,709 | $162,002,874 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,222,498 | $157,090,992 | |
| 6 | AMGN |
Amgen Inc
|
266,650 | $96,559,297 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
605,105 | $76,448,965 | |
| 8 | PFE |
Pfizer Inc
|
2,789,125 | $67,162,129 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $467,038,889 | 389,384 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $365,962,685 | 397,885 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $441,135,761 | 410,481 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $315,777,469 | 413,863 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $328,455,744 | 421,351 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $345,918,362 | 418,833 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $323,561,412 | 419,121 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $379,854,747 | 428,759 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $400,071,124 | 441,882 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $348,513,632 | 447,984 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $263,075,293 | 451,306 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $244,018,158 | 454,300 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $215,394,540 | 459,283 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $159,322,496 | 463,929 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $168,066,895 | 459,400 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $157,513,808 | 487,131 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $156,210,771 | 481,790 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $138,398,610 | 483,286 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $133,150,469 | 482,045 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $122,498,550 | 530,182 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $126,383,581 | 550,643 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $107,514,536 | 575,498 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $103,519,348 | 613,121 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $93,307,070 | 630,368 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $118,149,345 | 719,633 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $105,436,355 | 760,066 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||